188 related articles for article (PubMed ID: 24656371)
1. Novel Pullulan-Eudragit® S100 blend microparticles for oral delivery of risedronate: formulation, in vitro evaluation and tableting of blend microparticles.
de Arce Velasquez A; Ferreira LM; Stangarlin MF; da Silva Cde B; Rolim CM; Cruz L
Mater Sci Eng C Mater Biol Appl; 2014 May; 38():212-7. PubMed ID: 24656371
[TBL] [Abstract][Full Text] [Related]
2. Risedronate-loaded Eudragit S100 microparticles formulated into tablets.
Velasquez AA; Mattiazzi J; Ferreira LM; Pohlmann L; Silva CB; Rolim CM; Cruz L
Pharm Dev Technol; 2014 May; 19(3):263-8. PubMed ID: 23506303
[TBL] [Abstract][Full Text] [Related]
3. Comparison of simple Eudragit microparticles loaded with prednisolone and Eudragit-coated chitosan-succinyl-prednisolone conjugate microparticles: Part I. Particle characteristics and in vitro evaluation as a colonic delivery system.
Onishi H; Kikuchi H; Machida Y
Drug Dev Ind Pharm; 2012 Jul; 38(7):800-7. PubMed ID: 22077373
[TBL] [Abstract][Full Text] [Related]
4. Implementation of mixture design for formulation of albumin containing enteric-coated spray-dried microparticles.
Shastri PN; Ubale RV; D'Souza MJ
Drug Dev Ind Pharm; 2013 Feb; 39(2):164-75. PubMed ID: 22591196
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
Maghsoodi M; Sadeghpoor F
Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
[TBL] [Abstract][Full Text] [Related]
6. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
Alhnan MA; Basit AW
Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
[TBL] [Abstract][Full Text] [Related]
7. Colon-targeted celecoxib-loaded Eudragit® S100-coated poly-ε-caprolactone microparticles: preparation, characterization and in vivo evaluation in rats.
Ghorab DM; Amin MM; Khowessah OM; Tadros MI
Drug Deliv; 2011; 18(7):523-35. PubMed ID: 21793779
[TBL] [Abstract][Full Text] [Related]
8. Spray-drying enteric polymers from aqueous solutions: a novel, economic, and environmentally friendly approach to produce pH-responsive microparticles.
Alhnan MA; Kidia E; Basit AW
Eur J Pharm Biopharm; 2011 Oct; 79(2):432-9. PubMed ID: 21439376
[TBL] [Abstract][Full Text] [Related]
9. Enteric controlled-release pantoprazole-loaded microparticles prepared by using Eudragit S100 and poly(epsilon-caprolactone) blend.
Raffin RP; Colomé LM; Guterres SS; Pohlmann AR
Pharm Dev Technol; 2007; 12(5):463-71. PubMed ID: 17963146
[TBL] [Abstract][Full Text] [Related]
10. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.
Rawat M; Saraf S; Saraf S
AAPS PharmSciTech; 2007 Dec; 8(4):E116. PubMed ID: 18181537
[TBL] [Abstract][Full Text] [Related]
11. Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery.
Kendall RA; Alhnan MA; Nilkumhang S; Murdan S; Basit AW
Eur J Pharm Sci; 2009 Jun; 37(3-4):284-90. PubMed ID: 19491017
[TBL] [Abstract][Full Text] [Related]
12. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations.
Khan MZ; Stedul HP; Kurjaković N
Drug Dev Ind Pharm; 2000 May; 26(5):549-54. PubMed ID: 10789067
[TBL] [Abstract][Full Text] [Related]
13. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
Krishnamachari Y; Madan P; Lin S
Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
[TBL] [Abstract][Full Text] [Related]
14. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
[TBL] [Abstract][Full Text] [Related]
15. Development of HPMC and Eudragit S100 blended microparticles containing sodium pantoprazole.
Raffin RP; Colomé LM; Haas SE; Jornada DS; Pohlmann AR; Guterres SS
Pharmazie; 2007 May; 62(5):361-4. PubMed ID: 17557744
[TBL] [Abstract][Full Text] [Related]
16. The robustness and flexibility of an emulsion solvent evaporation method to prepare pH-responsive microparticles.
Nilkumhang S; Basit AW
Int J Pharm; 2009 Jul; 377(1-2):135-41. PubMed ID: 19515519
[TBL] [Abstract][Full Text] [Related]
17. Methacrylate micro/nano particles prepared by spray drying: a preliminary in vitro/in vivo study.
Muñoz Ortega B; Sallam MA; Marín Boscá MT
Drug Deliv; 2016 Sep; 23(7):2439-2444. PubMed ID: 25715809
[TBL] [Abstract][Full Text] [Related]
18. pH-sensitive microparticles for oral drug delivery based on alginate/oligochitosan/Eudragit(®) L100-55 "sandwich" polyelectrolyte complex.
Calija B; Cekić N; Savić S; Daniels R; Marković B; Milić J
Colloids Surf B Biointerfaces; 2013 Oct; 110():395-402. PubMed ID: 23751419
[TBL] [Abstract][Full Text] [Related]
19. Encapsulation of poorly soluble basic drugs into enteric microparticles: a novel approach to enhance their oral bioavailability.
Alhnan MA; Murdan S; Basit AW
Int J Pharm; 2011 Sep; 416(1):55-60. PubMed ID: 21679756
[TBL] [Abstract][Full Text] [Related]
20. Multiple unit gastroretentive drug delivery systems: a new preparation method for low density microparticles.
Streubel A; Siepmann J; Bodmeier R
J Microencapsul; 2003; 20(3):329-47. PubMed ID: 12881114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
